Vortex/hurricane keratopathy.(CORNEA)
Vortex keratopathyCorneal verticillateCDK4/6 inhibitorCorneal confocal microscopyCyclin-dependent kinase (CDK) 4/6 inhibitors are novel anticancer drugs that can arrest the cell cycle and halt the progression of cancers. This study presents a rare case of vortex keratopathy associated with the use ...
Purpose. To compare the morphology of two types of vortex keratopathy: amiodarone-induced keratopathy and the Fabry disease-associated keratopathy. Patients and Methods. Eight patients who were receiving oral amiodarone therapy and 3 patients with Fabry disease, a mother and her 2 daughters, were exa...
of atovaquone.A patient with acquired immunodeficiency syndrome (AIDS) with pulmonary Pneumocystis carinii was treated with 750 mg of atovaquone three times a day.Similar to previous findings of drug-induced vortex keratopathy, atovaquone vortex keratopathy is presumably caused by its lipophilic properties...
Amiodarone: Vortex keratopathy: case report
Vortex (Hurricane) KeratopathyThe course travelled by corneal epithelial cells from their stem cell niche at the limbus toward the vertex of the cornea is normally not evident due to their transparency, but in certain conditions, the epithelial cells can be rendered visible to the clinician. In ...
A unique feature that preceded or coexisted with the conjunctival signs was unilateral vortex keratopathy seen in all 3 patients, independent of the stage of the disease at which they presented.Conclusions:Vortex keratopathy can be a presenting feature in patients with OMMP. A complete ocular ...
Ibuprofen: First report of vortex keratopathy: case reportEye-disorders, drug-inducedIbuprofen, adverse reactionsReactions Weekly
Glaucoma Services, Department of Ophthalmology, All India Institute of Medical Sciences, Kalyani, West Bengal, IndiaGrace Lhinghoithem HaokipGlaucoma Services, Department of Ophthalmology, All India Institute of Medical Sciences, Kalyani, West Bengal, India...
METHODS: We conducted a retrospective chart review of patients with uveitis and MS at two uveitis centres (Portland, Oregon, USA and Heidelberg, Germany). Baseline characteristics and ophthalmic data were collected at the patient's first and last visits. Additionally, neurological records were ...